Screening for cystic fibrosis by a stool trypsin method

Area of Science:

• Medical Screening
• Pediatrics
• Genetic Disorders

Background:

• Cystic fibrosis (CF) diagnosis relies on sweat tests, which can be invasive.
• Newborn screening aims to detect CF early for timely intervention.
• Developing cost-effective and accurate screening methods is crucial.

Purpose of the Study:

• To evaluate the efficacy of a mass screening method for cystic fibrosis using a stool trypsin assay in newborns.
• To assess the specificity and sensitivity of this screening method compared to traditional tests.

Main Methods:

• A retrospective evaluation of a mass screening program involving 20,000 newborns.
• The screening utilized a trypsin assay on stool samples dried on filter paper.
• Confirmatory sweat tests were performed on infants with abnormal screening results.

Main Results:

• The screening identified three cases of cystic fibrosis among the 20,000 infants.
• Only 7 infants required confirmatory sweat tests, indicating high specificity.
• At least 2 false-negative results were observed, with affected infants showing normal pancreatic function.

Conclusions:

• The stool trypsin assay is a highly specific and cost-effective screening tool for cystic fibrosis.
• While not ideal due to potential false negatives in cases with normal pancreatic function, it represents the best available screening option currently.
• Early detection through this method facilitates prompt management of cystic fibrosis.